To request a media interview, please reach out to experts using the faculty directories for each of our six schools, or contact Jess Hunt-Ralston, College of Sciences communications director. A list of faculty experts is also available to journalists upon request.
During decision-making, brain shows multiple distinct subtypes of activity
Brain imaging research may be grappling with a fresh challenge. Scanning the brain of a single person can reveal the areas they use to complete a task, although the exact pattern differs from person to person. But averaging the results across many people—as scientists often do—fails to capture some important nuances, a new functional MRI (fMRI) study suggests.
The brain tackles decision-making tasks in particular through several different categories of brain activity, rather than a single one, according to the study, published in Nature Communications in February by a team that includes School of Psychology researchers. Across three decision-making tasks, participants’ brains differentially activated and suppressed various regions and networks in ways that could be grouped into distinct categories, or subtypes, highlighting the variability of neural signatures during behavior.
The Transmitter
How a Biofilm’s Strange Shape Emerges From Cellular Geometry
Biofilms have emergent properties: traits that appear only when a system of individual items interacts. It was this emergence that attracted School of Physics Associate Professor Peter Yunker to the microbial structures. Trained in soft matter physics — the study of materials that can be structurally altered — he is interested in understanding how the interactions between individual bacteria result in the higher-order structure of a biofilm
Recently, in his lab at the Georgia Institute of Technology, Yunker and his team created detailed topographical maps of the three-dimensional surface of a growing biofilm. These measurements allowed them to study how a biofilm’s shape emerges from millions of infinitesimal interactions among component bacteria and their environment. In 2024 in Nature Physics, they described the biophysical laws that control the complex aggregation of bacterial cells.
The work is important, Yunker said, not only because it can help explain the staggering diversity of one of the planet’s most common life forms, but also because it may evoke life’s first, hesitant steps toward multicellularity.
Quanta Magazine
Inorganic mechanism driving mysterious surge of powerful greenhouse gas
Earth and Atmospheric Sciences Professor Jennifer Glass comments on a paper recently published in Science that details “photochemodenitrification,” a nitrous oxide production pathway through which sunlight induces substantial and consistent nitrous oxide formation under oxic abiotic conditions in fresh and marine surface waters.
“I think it’s a beautiful [study],’ says Glass, noting that researchers have previously shown similar light-driven processes in atmospheric aerosols, but never in aquatic environments. “As we’ve been sequencing more and more genomes in the environment a lot of us have moved really into that -omics space, looking for key markers for genes … This just goes to show that sometimes it’s not biological,” she says. “You have to think outside the box and consider all the chemistry that can be happening, not just the enzymes.”
Chemistry World
Atlanta Science Festival takes place at Georgia Tech
Georgia Tech’s campus was recently the site of an interactive celebration of science. The 2025 Atlanta Science Festival launched Saturday, March 8, 2025 at Georgia Tech. Dozens of exhibits were spread out all over the campus, with hands-on STEM activities, demonstrations, and information about the research currently happening on campus.
(A similar story appeared at WABE.)
Atlanta News First
New Glaucoma Treatment May Save Vision
Four million Americans suffer from glaucoma, an incurable eye disease that slowly degrades peripheral vision and eventually leads to blindness. A new treatment could potentially stop this degradation and possibly save people’s vision before it’s too late.
Raquel Lieberman, a professor in the School of Chemistry and Biochemistry and the Parker H. Petit Institute for Bioengineering and Bioscience, and her lab team have discovered two new antibodies with promise to treat glaucoma. The antibodies can break down the protein myocilin, which, when it malfunctions, can cause glaucoma.
Lieberman’s group recently published this research in the Proceedings of the National Academy of Sciences: Nexus.
Futurity